Companies Look Past Immediate Coronavirus Treatment To Drugs That Help With Long-Term Damage
Many patients who recover from COVID-19 are still left with long-term lung damage, and there's few treatment options out there to help them. Some drugmakers are seeing an opportunity to get into the game where they couldn't when it comes to immediate treatment.